Interventional cardiologists share insights into the progress of procedures and devices such as Impella and TAVI for acute ...

The cause of heart disease is generally clogged arteries. These blood vessels can be blocked by fatty plaque that contains ...

An in-home foot scanner that uses artificial intelligence (AI) to recognise the warning signs of heart failure could help ...

The FDA has granted a breakthrough device designation to the BiVACOR Total Artificial Heart. Made of titanium, the device uses a magnetically levitated rotor to pump blood in adult patients with ...

Objectives General practitioners (GPs) play a key role in heart failure (HF) management. Despite multiple guidelines, the management of patients with HF in primary care is suboptimal. Therefore, all ...

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...

Hospitalization for heart failure (HF) is associated with increased risk of death among patients with chronic HF. The degree to which hospitalization for HF is a distinct biologic entity with ...

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

The effects of treatments for heart failure (HF) may vary among patients according to left ventricular ejection fraction (LVEF). In FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety ...